
Evolus, Inc. — Investor Relations & Filings
Evolus, Inc. is a performance beauty company focused on the medical aesthetics market. The company develops and commercializes a portfolio of aesthetic products for the cash-pay sector, targeting both healthcare practitioners and consumers. Its flagship product is Jeuveau® (prabotulinumtoxinA-xvfs), a neurotoxin used for the temporary improvement of moderate to severe glabellar lines in adults. Evolus is expanding its offerings with the Evolysse™ line of hyaluronic acid-based dermal fillers, designed to correct facial wrinkles and folds. The company supports its customer-centric approach with consumer engagement platforms, including the Evolus Rewards loyalty program and the Club Evolus subscription service.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - Evolus, Inc. (0001570562) (Filer) | 2026-04-29 | English | |
| ARS - Evolus, Inc. (0001570562) (Filer) | 2026-04-29 | English | |
| SCHEDULE 13G/A - Evolus, Inc. (0001570562) (Subject) | 2026-03-26 | English | |
| 4 - Evolus, Inc. (0001570562) (Issuer) | 2026-03-21 | English | |
| 4 - Evolus, Inc. (0001570562) (Issuer) | 2026-03-21 | English | |
| 4 - Evolus, Inc. (0001570562) (Issuer) | 2026-03-19 | English |
Browse filings by year
11 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Jenburkt Pharmaceuticals Ltd.
Develops and manufactures healthcare formulations for vario…
|
524731 | IN | Manufacturing |
|
JETEMA Co.,Ltd.
Develops and manufactures toxins, fillers, and threads for …
|
216080 | KR | Manufacturing |
|
Jfl Life Sciences Limited
Manufactures and markets diverse pharmaceutical formulation…
|
JFLLIFE | IN | Manufacturing |
|
JIANERKANG MEDICAL CO., LTD.
Manufacturer of medical consumables, surgical dressings, an…
|
603205 | CN | Manufacturing |
|
JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD.
Biopharmaceutical firm developing innovative anti-HIV and a…
|
688488 | CN | Manufacturing |
|
Jiangsu Bioperfectus Technologies Co., Ltd.
Develops molecular diagnostic solutions and systems for inf…
|
688399 | CN | Manufacturing |
|
JIANGSU COWIN BIOTECH CO., LTD.
Develops molecular biology reagents and kits for research a…
|
688426 | CN | Manufacturing |
|
Jiangsu Jibeier Pharmaceutical Co.,Ltd.
Develops innovative chemical and biological drugs for ophth…
|
688566 | CN | Manufacturing |
|
Jiangsu Kanion Pharmaceutical Co.,Ltd.
Develops and manufactures modern Traditional Chinese Medici…
|
600557 | CN | Manufacturing |
|
Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
Develops and manufactures pharmaceuticals for cardiovascula…
|
600513 | CN | Manufacturing |
Evolus, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33040/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33040 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33040 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33040 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33040}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Evolus, Inc. (id: 33040)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.